Production & Manufacturing
Press Releases
U.S. Govt. Selects Grand River Aseptic Manufacturing to Help Combat COVID-19
Grand River Aseptic Manufacturing, a leading parenteral contract development and manufacturing organization (CDMO), has been selected by the U.S. Department of Health and Human Services and the U.S. Department of Defense to support the expansion of the United States’...
Press Releases
Catalent Adds Potent Manufacturing Capabilities at its Buenos Aires, Argentina Site
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing, solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that it will expand its Argentinian site in Loma Hermosa, Buenos Aires. The expansion,...
Press Releases
Lonza’s Ibex Dedicate to Support the Commercial Manufacture of Kodiak’s KSI-301
We are committed to supporting Kodiak as they bring their highly innovative, sight-saving treatment option to patients with vision-threatening retinal diseases. Since 2014, we have been partnering with Kodiak to support the supply of KSI-301 drug substance for use...
News
Bionova Begins Construction of New Manufacturing Center
Bionova Scientific, a biologics CDMO with deep protein production, cell line development, process development and analytical expertise, has initiated construction of its new biologics manufacturing facility. Construction will be completed in approximately 10 months, with commissioning scheduled for Q3...
Press Releases
BD Partners with U.S. Government on $70 Million Manufacturing Infrastructure Project for Mass Vaccination Campaigns
BD, a leading global medical technology company announced the formation of a strategic, public-private partnership with the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Health and Human Services Office of the Assistant Secretary for Preparedness...
Press Releases
Merck Opens its Largest M Lab Collaboration Center in Shanghai
Merck, a leading science and technology company, opened its M LabTM Collaboration Center in Shanghai, the company’s largest of nine centers worldwide.
“With the booming pharmaceutical industry in Asia and greater emphasis on novel drug therapies, we see an increase...
Drug Research
Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement
Samsung Biologics and ImmuneOncia Therapeutics held a signing ceremony for a contract to develop and manufacture five candidate molecules, expanding upon the two companies existing CDO partnership first established in 2018.
“As we already have a track record of successful...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read